Increased sedation requirements in patients receiving extracorporeal membrane oxygenation for respiratory and cardiorespiratory failure

Anaesthesia and Intensive Care

Volumn 40, Issue 4, 2012, Pages 648-655

  Shekar, K ^a,b   Roberts, J A ^a,b   Mullany, D V ^a,b   Corley, A ^a,c   Fisquet, S ^a,d   Bull, T N ^a,d   Barnett, A G ^a,e   Fraser, J F ^a,d,f  

^a THE PRINCE CHARLES HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c GRIFFITH UNIVERSITY   (Australia)

^d Critical Care Medicine   (Australia)

^e QUEENSLAND UNIVERSITY OF TECHNOLOGY   (Australia)

^f Adult Intensive Care Unit   (Australia)

Author keywords

Cardiorespiratory failure; Drug toxicity; Extracorporeal membrane oxygenation; Pharmacokinetics; Sedation and analgesia

Indexed keywords

FENTANYL; MIDAZOLAM; MORPHINE; PROPOFOL; VECURONIUM;

ADOLESCENT; ADULT; AGED; ANALGESIA; ARTICLE; CARDIOPULMONARY INSUFFICIENCY; CLINICAL ARTICLE; DRUG DOSE INCREASE; EXTRACORPOREAL OXYGENATION; FEMALE; HUMAN; MALE; MEDICAL RECORD REVIEW; RESPIRATORY FAILURE; RETROSPECTIVE STUDY; SEDATION;

EID: 84865103692     PISSN: 0310057X     EISSN: 14480271     Source Type: Journal    
DOI: 10.1177/0310057x1204000411     Document Type: Article

References (53)

1. Bartlett RH, Gattinoni L. Current status of extracorporeal life support (ECMO) for cardiopulmonary failure. Minerva Anestesiol 2010; 76:534-540.
2. Strueber M. Bridges to lung transplantation. Curr Opin Organ Transplant 2011; 16:458-461.
3. Fitzgerald D, Ging A, Burton N, Desai S, Elliott T, Edwards L. The use of percutaneous ECMO support as a 'bridge to bridge' in heart failure patients: a case report. Perfusion 2010; 25:321-235, 327.
4. Thiagarajan RR, Brogan TV, Scheurer MA, Laussen PC, Rycus T, Bratton SL. Extracorporeal membrane oxygenation to support cardiopulmonary resuscitation in adults. Ann Thorac Surg 2009; 87:778-785.
5. Booth KL, Roth SJ, Perry SB, del Nido PJ, Wessel DL, Laussen PC. Cardiac catheterization of patients supported by extracorporeal membrane oxygenation. J Am Coll Cardiol 2002; 40:1681-1686.
6. Stulak JM, Dearani JA, Burkhart HM, Barnes RD, Scott PD, Schears GJ. ECMO cannulation controversies and complications. Semin Cardiothorac Vasc Anesth 2009; 13:176-182.
7. Riley JB, Scott PD, Schears GJ. Update on safety equipment for extracorporeal life support (ECLS) circuits. Semin Cardiothorac Vasc Anesth 2009; 13:138-145.
8. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW. Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 1976; 22:80-93.
9. Peek GJ, Mugford M, Tiruvoipati R, Wilson A, Allen E, Thalanany MM et al. Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial. Lancet 2009; 374:1351-1363.
10. Davies A, Jones D, Bailey M, Beca J, Bellomo R, Blackwell N et al. Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. JAMA 2009; 302:1888-1895.
11. Lewandowski K. Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 2000; 4:156-168.
12. Pipeling MR, Fan E. Therapies for refractory hypoxemia in acute respiratory distress syndrome. JAMA 2010; 304:2521-2527.
13. E san A, Hess DR, Raoof S, George L, Sessler CN. Severe hypoxemic respiratory failure: part 1 - ventilatory strategies. Chest 2010; 137:1203-1216.
14. Raoof S, Goulet K, Esan A, Hess DR, Sessler CN. Severe hypoxemic respiratory failure: part 2 - nonventilatory strategies. Chest 2010; 137:1437-1448.
15. ECLS Registry Report (International summary). Extracorporeal Life Support Organisation. Ann Arbor, MI: Extracorporeal Life Support Organisation, 2011.
16. Sessler CN, Wilhelm W. Analgesia and sedation in the intensive care unit: an overview of the issues. Crit Care 2008; 12 (Suppl 3):S1.
17. Brook AD, Ahrens TS, Schaiff R, Prentice D, Sherman G, Shannon W et al. Effect of a nursing-implemented sedation protocol on the duration of mechanical ventilation. Crit Care Med 1999; 27:2609-2615.
18. Kress JP, Vinayak AG, Levitt J, Schweickert WD, Gehlbach BK, Zimmerman F et al. Daily sedative interruption in mechanically ventilated patients at risk for coronary artery disease. Crit Care Med 2007; 35:365-371.
19. Schweickert WD, Gehlbach BK, Pohlman AS, Hall JB, Kress JP. Daily interruption of sedative infusions and complications of critical illness in mechanically ventilated patients. Crit Care Med 2004; 32:1272-1276.
20. L inden V, Palmer K, Reinhard J, Westman R, Ehren H, Granholm T et al. High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 2000; 26:1630-1637.
21. Dagan O, Klein J, Gruenwald C, Bohn D, Barker G, Koren G. Preliminary studies of the effects of extracorporeal membrane oxygenator on the disposition of common pediatric drugs. Ther Drug Monit 1993; 15:263-266.
22. Elliott ES, Buck ML. Phenobarbital dosing and pharmacokinetics in a neonate receiving extracorporeal membrane oxygenation. Ann Pharmacother 1999; 33:419-422.
23. Rosen DA, Rosen KR. Midazolam for sedation in the paediatric intensive care unit. Intensive Care Med 1991; 17 (Suppl 1):S15-19.
24. Dagan O, Klein J, Bohn D, Koren G. Effects of extracorporeal membrane oxygenation on morphine pharmacokinetics in infants. Crit Care Med 1994; 22:1099-1101.
25. Buck ML. Pharmacokinetic changes during extracorporeal membrane oxygenation: implications for drug therapy of neonates. Clin Pharmacokinet 2003; 42:403-417.
26. Caron E, Maguire DP. Current management of pain, sedation, and narcotic physical dependency of the infant on ECMO. J Perinat Neonatal Nurs 1990; 4:63-74.
27. Arnold JH, Truog RD, Orav EJ, Scavone JM, Hershenson MB. Tolerance and dependence in neonates sedated with fentanyl during extracorporeal membrane oxygenation. Anesthesiology 1990; 73:1136-1140.
28. Ahsman MJ, Hanekamp M, Wildschut ED, Tibboel D, Mathot RAA. Population pharmacokinetics of midazolam and its metabolites during venoarterial extracorporeal membrane oxygenation in neonates. Clin Pharmacokinet 2010; 49:407-419.
29. Mulla H, Lawson G, von Anrep C, Burke MD, Upton DU, Firmin RK et al. In vitro evaluation of sedative drug losses during extracorporeal membrane oxygenation. Perfusion 2000; 15:21-26.
30. Peters JWB, Anderson BJ, Simons SHP, Uges DRA, Tibboel D. Morphine pharmacokinetics during venoarterial extracorporeal membrane oxygenation in neonates. Intensive Care Med 2005; 31:257-263.
31. Peters JWB, Anderson BJ, Simons SHP, Uges DRA, Tibboel D. Morphine metabolite pharmacokinetics during venoarterial extra corporeal membrane oxygenation in neonates. Clin Pharmacokinet 2006; 45:705-714.
32. Geiduschek JM, Lynn AM, Bratton SL, Sanders JC, Levy FH, Haberkern CM et al. Morphine pharmacokinetics during continuous infusion of morphine sulfate for infants receiving extracorporeal membrane oxygenation. Crit Care Med 1997; 25:360-364.
33. L euschen MP, Willett LD, Hoie EB, Bolam DL, Bussey ME, Goodrich PD et al. Plasma fentanyl levels in infants undergoing extracorporeal membrane oxygenation. J Thorac Cardiovasc Surg 1993; 105:885-891.
34. Mulla H, McCormack P, Lawson G, Firmin RK, Upton DR. Pharmacokinetics of midazolam in neonates undergoing extracorporeal membrane oxygenation. Anesthesiology 2003; 99:275-282.
35. Mulla H, Lawson G, Peek GJ, Firmin RK, Upton DR. Plasma concentrations of midazolam in neonates receiving extracorporeal membrane oxygenation. ASAIO J 2003; 49:41-47.
36. Bhatt-Meht V, Annich G. Sedative clearance during extracorporeal membrane oxygenation. Perfusion 2005; 20:309-315.
37. Hammaren E, Rosenberg PH, Hynynen M. Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro. Br J Anaesth 1999; 82:38-40.
38. Mehta NM, Halwick DR, Dodson BL, Thompson JE, Arnold JH. Potential drug sequestration during extracorporeal membrane oxygenation: results from an ex vivo experiment. Intensive Care Med 2007; 33:1018-1024.
39. Wildschut ED, Ahsman MJ, Allegaert K, Mathot RAA, Tibboel D. Determinants of drug absorption in different ECMO circuits. Intensive Care Med 2010; 36:2109-2116.
40. Rosen DA, Rosen KR, Silvasi DL. In vitro variability in fentanyl absorption by different membrane oxygenators. J Cardiothorac Anesth 1990; 4:332-335.
41. Roy BJ, Rycus P, Conrad SA, Clark RH. The changing demographics of neonatal extracorporeal membrane oxygenation patients reported to the Extracorporeal Life Support Organization (EL SO) Registry. Pediatrics 2000; 106:1334-1338.
42. Mulla HGL, Firmin RK, David RU. Drug isposition during extracorporeal membrane oxygenation. Paediatric and Perinatal Drug Therapy 2001; 4:109-120.
43. Boucher BA, Wood GC, Swanson JM. Pharmacokinetic changes in critical illness. Crit Care Clin 2006; 22:255-271, vi.
44. Varghese JM, Roberts JA, Lipman J. Pharmacokinetics and pharmacodynamics in critically ill patients. Curr Opin Anaesthesiol 2010; 23:472-478.
45. Roberts JA. Using PK/PD to optimize antibiotic dosing for critically ill patients. Curr Pharm Biotechnol 2011; 12:2070-2079.
46. McILwain RB, Timpa JG, Kurundkar AR, Holt DW, Kelly DR, Hartman YE et al. Plasma concentrations of inflammatory cytokines rise rapidly during ECMO-related SIRS due to the release of preformed stores in the intestine. Lab Invest 2010; 90:128-139.
47. Vardi A, Jessen ME, Chao RY, Brink LW, Levin DL, Johnson RL. Effect of extracorporeal membrane oxygenation flow on pulmonary capillary blood flow. Crit Care Med 1995; 23:726-732.
48. Many M, Soroff HS, Birtwell WC, Giron F, Wise H, Deterling RA Jr. The physiologic role of pulsatile and nonpulsatile blood flow. II. Effects on renal function. Arch Surg 1967; 95:762-767.
49. Shevde K, DeBois WJ. Pro: pulsatile flow is preferable to nonpulsatile flow during cardiopulmonary bypass. J Cardiothorac Anesth 1987; 1:165-168.
50. Schetz M. Drug dosing in continuous renal replacement therapy: general rules. Curr Opin Crit Care 2007; 13:645-651.
51. L eBlanc JM, Dasta JF, Kane-Gill SL. Role of the bispectral index in sedation monitoring in the ICU. Ann Pharmacother 2006; 40:490-500.
52. Shekar K, Fung YL , Diab S, Mullandy DV, McDonald CI, Dunster KR, et al. Development of simulated and ovine models of ECLS to improve understanding of circuit-host interactions. Critical Care and Resuscitation 2012; 14:105-111.
53. Shekar JA. Pharmacokinetic changes in patients receiving extracorporeal membrane oxygenation. J Crit Care 2012; 18 Apr [Epub ahead of print].